Why is it more difficult to treat fungal infections than bacterial infections in humans?

1. Currie BP, Casadevall A. Estimation of the prevalence of Cryptococcus neoformans infection in New York City in 1991. The First National Conference on Human Retroviruses and Related Infections. 1993; Washington, D.C. [Google Scholar]

2. Fisher MC, Henk DA, Briggs CJ, Brownstein JS, Madoff LC, McCraw SL, Gurr SJ. Emerging fungal threats to animal, plant and ecosystem health. Nature. 2012;484(7393):186–94. nature10947 [pii]; doi: 10.1038/nature10947 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

3. Casadevall A. Fungi and the rise of mammals. PLoS Pathog. 2012;8(8):e1002808 PubMed PMID: 22916007. Pubmed Central PMCID: Pmc3420938. doi: 10.1371/journal.ppat.1002808 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

4. Robert VA, Casadevall A. Vertebrate endothermy restricts most fungi as potential pathogens. J Infect Dis. 2009;200(10):1623–6. doi: 10.1086/644642 [PubMed] [CrossRef] [Google Scholar]

5. Bergman A, Casadevall A. Mammalian endothermy optimally restricts fungi and metabolic costs. MBio. 2010;1(5). doi: 10.1128/mBio.00212-10 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

6. Casadevall A. Fungal virulence, vertebrate endothermy, and dinosaur extinction: is there a connection? Fungal Genet Biol. 2005;42(2):98–106. [PubMed] [Google Scholar]

7. Brown GD, Denning DW, Gow NA, Levitz SM, Netea MG, White TC. Hidden killers: human fungal infections. Sci Transl Med. 2012;4(165):165rv13 4/165/165rv13 [pii];-doi: 10.1126/scitranslmed.3004404 [PubMed] [CrossRef] [Google Scholar]

8. Rodrigues ML, Albuquerque PC. Searching for a change: The need for increased support for public health and research on fungal diseases. PLoS Negl Trop Dis. 2018;12(6):e0006479 PubMed PMID: 29902170. Pubmed Central PMCID: Pmc6001980. doi: 10.1371/journal.pntd.0006479 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

9. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23(4):525–30. [PubMed] [Google Scholar]

10. Gustafson TL, Kaufman L, Weeks R, Ajello L, Hutcheson RH Jr., Wiener SL, Lambe DW Jr., Sayvetz TA, Schaffner W. Outbreak of acute pulmonary histoplasmosis in members of a wagon train. Am J Med. 1981;71(5):759–65. [PubMed] [Google Scholar]

11. Andes D, Casadevall A. Insights into fungal pathogenesis from the iatrogenic epidemic of Exserohilum rostratum fungal meningitis. Fungal Genet Biol. 2013;61:143–5. PubMed PMID: 24012946. doi: 10.1016/j.fgb.2013.08.014 [PubMed] [CrossRef] [Google Scholar]

12. Stop neglecting fungi. Nat Microbiol. 2017;2:17120 PubMed PMID: 28741610. doi: 10.1038/nmicrobiol.2017.120 [PubMed] [CrossRef] [Google Scholar]

13. Gow NAR, Amin T, McArdle K, Brown AJP, Brown GD, Warris A, The Wtsa-Mmfi C. Strategic Research Funding: A Success Story for Medical Mycology. Trends Microbiol. 2018. PubMed PMID: 29909043. doi: 10.1016/j.tim.2018.05.014 [PubMed] [CrossRef] [Google Scholar]

14. Kyriakidis I, Tragiannidis A, Zundorf I, Groll AH. Invasive fungal infections in paediatric patients treated with macromolecular immunomodulators other than tumour necrosis alpha inhibitors. Mycoses. 2017;60(8):493–507. PubMed PMID: 28444889. doi: 10.1111/myc.12621 [PubMed] [CrossRef] [Google Scholar]

15. Tsiodras S, Samonis G, Boumpas DT, Kontoyiannis DP. Fungal infections complicating tumor necrosis factor alpha blockade therapy. Mayo Clin Proc. 2008;83(2):181–94. PubMed PMID: 18241628. [PubMed] [Google Scholar]

16. Datta K, Hamad M. Immunotherapy of Fungal Infections. Immunol Invest. 2015;44(8):738–76. PubMed PMID: 26575463. doi: 10.3109/08820139.2015.1093913 [PubMed] [CrossRef] [Google Scholar]

17. Edwards JE Jr., Schwartz MM, Schmidt CS, Sobel JD, Nyirjesy P, Schodel F, Marchus E, Lizakowski M, DeMontigny EA, Hoeg J, Holmberg T, Cooke MT, Hoover K, Edwards L, Jacobs M, Sussman S, Augenbraun M, Drusano M, Yeaman MR, Ibrahim AS, Filler SG, Hennessey JP Jr. A Fungal Immunotherapeutic Vaccine (NDV-3A) for Treatment of Recurrent Vulvovaginal Candidiasis-A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial. Clin Infect Dis. 2018;66(12):1928–36. PubMed PMID: 29697768. Pubmed Central PMCID: Pmc5982716. doi: 10.1093/cid/ciy185 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

18. Casadevall A, Pirofski LA. A Therapeutic Vaccine for Recurrent Vulvovaginal Candidiasis. Clin Infect Dis. 2018;66(12):1937–9. PubMed PMID: 29697770. doi: 10.1093/cid/ciy188 [PubMed] [CrossRef] [Google Scholar]

19. Casadevall A, Pirofski LA. Immunoglobulins in defense, pathogenesis, and therapy of fungal diseases. Cell Host Microbe. 2012;11(5):447–56. S1931-3128(12)00101-1 [pii]; doi: 10.1016/j.chom.2012.04.004 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

20. Larsen RA, Pappas PG, Perfect JR, Aberg JA, Casadevall A, Cloud GA, James R, Filler S, Dismukes WE. A phase I evaluation of the safety and pharmacodynamic activity of a murine-derived monoclonal antibody 18B7 in subjects with treated cryptococcal meningitis. Antimicrob Agents Chemother. 2005;49:952–8. [PMC free article] [PubMed] [Google Scholar]

21. Zhao G, Zaidi TS, Bozkurt-Guzel C, Zaidi TH, Lederer JA, Priebe GP, Pier GB. Efficacy of Antibody to PNAG Against Keratitis Caused by Fungal Pathogens. Invest Ophthalmol Vis Sci. 2016;57(15):6797–804. PubMed PMID: 28002842. Pubmed Central PMCID: Pmc5215555. doi: 10.1167/iovs.16-20358 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

22. Wharton RE, Stefanov EK, King RG, Kearney JF. Antibodies generated against Streptococci protect in a mouse model of disseminated aspergillosis. J Immunol. 2015;194(9):4387–96. PubMed PMID: 25821219. Pubmed Central PMCID: Pmc4402265. doi: 10.4049/jimmunol.1401940 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

23. Miceli MH, Maertens J. Role of Non-Culture-Based Tests, with an Emphasis on Galactomannan Testing for the Diagnosis of Invasive Aspergillosis. Semin Respir Crit Care Med. 2015;36(5):650–61. PubMed PMID: 26398532. doi: 10.1055/s-0035-1562892 [PubMed] [CrossRef] [Google Scholar]

24. Temfack E, Kouanfack C, Mossiang L, Loyse A, Fonkoua MC, Molloy SF, Koulla-Shiro S, Delaporte E, Dromer F, Harrison T, Lortholary O. Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naive Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test. Front Microbiol. 2018;9:409 PubMed PMID: 29593675. Pubmed Central PMCID: Pmc5859387. doi: 10.3389/fmicb.2018.00409 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

25. Mery A, Sendid B, Francois N, Cornu M, Poissy J, Guerardel Y, Poulain D. Application of Mass Spectrometry Technology to Early Diagnosis of Invasive Fungal Infections. J Clin Microbiol. 2016;54(11):2786–97. PubMed PMID: 27605710. Pubmed Central PMCID: Pmc5078558. doi: 10.1128/jcm.01655-16 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

26. Gu Z, Buelow DR, Petraitiene R, Petraitis V, Walsh TJ, Hayden RT. Quantitative multiplexed detection of common pulmonary fungal pathogens by labeled primer polymerase chain reaction. Arch Pathol Lab Med. 2014;138(11):1474–80. PubMed PMID: 25357108. doi: 10.5858/arpa.2013-0592-OA [PubMed] [CrossRef] [Google Scholar]

27. Buitrago MJ, Aguado JM, Ballen A, Bernal-Martinez L, Prieto M, Garcia-Reyne A, Garcia-Rodriguez J, Rodriguez-Tudela JL, Cuenca-Estrella M. Efficacy of DNA amplification in tissue biopsy samples to improve the detection of invasive fungal disease. Clin Microbiol Infect. 2013;19(6):E271–7. PubMed PMID: 23464751. doi: 10.1111/1469-0691.12110 [PubMed] [CrossRef] [Google Scholar]

28. Rolle AM, Hasenberg M, Thornton CR, Solouk-Saran D, Mann L, Weski J, Maurer A, Fischer E, Spycher PR, Schibli R, Boschetti F, Stegemann-Koniszewski S, Bruder D, Severin GW, Autenrieth SE, Krappmann S, Davies G, Pichler BJ, Gunzer M, Wiehr S. ImmunoPET/MR imaging allows specific detection of Aspergillus fumigatus lung infection in vivo. Proc Natl Acad Sci U S A. 2016;113(8):E1026–33. PubMed PMID: 26787852. Pubmed Central PMCID: Pmc4776455. doi: 10.1073/pnas.1518836113 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

29. Fisher MC, Hawkins NJ, Sanglard D, Gurr SJ. Worldwide emergence of resistance to antifungal drugs challenges human health and food security. Science. 2018;360(6390):739–42. PubMed PMID: 29773744. doi: 10.1126/science.aap7999 [PubMed] [CrossRef] [Google Scholar]

30. Bidaud AL, Chowdhary A, Dannaoui E. Candida auris: An emerging drug resistant yeast - A mini-review. J Mycol Med. 2018. PubMed PMID: 30030072. doi: 10.1016/j.mycmed.2018.06.007 [PubMed] [CrossRef] [Google Scholar]

31. Chowdhary A, Kathuria S, Xu J, Meis JF. Emergence of azole-resistant aspergillus fumigatus strains due to agricultural azole use creates an increasing threat to human health. PLoS Pathog. 2013;9(10):e1003633 PubMed PMID: 24204249. Pubmed Central PMCID: Pmc3812019. doi: 10.1371/journal.ppat.1003633 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

32. Abdolrasouli A, Rhodes J, Beale MA, Hagen F, Rogers TR, Chowdhary A, Meis JF, Armstrong-James D, Fisher MC. Genomic Context of Azole Resistance Mutations in Aspergillus fumigatus Determined Using Whole-Genome Sequencing. MBio. 2015;6(3):e00536 PubMed PMID: 26037120. Pubmed Central PMCID: Pmc4453006. doi: 10.1128/mBio.00536-15 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

33. Perfect JR. The antifungal pipeline: a reality check. Nat Rev Drug Discov. 2017;16(9):603–16. PubMed PMID: 28496146. Pubmed Central PMCID: Pmc5760994. doi: 10.1038/nrd.2017.46 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

34. Zhai B, Wu C, Wang L, Sachs MS, Lin X. The antidepressant sertraline provides a promising therapeutic option for neurotropic cryptococcal infections. Antimicrob Agents Chemother. 2012;56(7):3758–66. PubMed PMID: 22508310. Pubmed Central PMCID: Pmc3393448. doi: 10.1128/aac.00212-12 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

35. Villanueva-Lozano H, Trevino-Rangel RJ, Gonzalez GM, Hernandez-Rodriguez PA, Camacho-Ortiz A, Castillo-Reyna L, Galindo-Alvarado SG, Martinez-Resendez MF. Clinical evaluation of the antifungal effect of sertraline in the treatment of cryptococcal meningitis in HIV patients: a single Mexican center experience. Infection. 2018;46(1):25–30. PubMed PMID: 28815430. doi: 10.1007/s15010-017-1059-3 [PubMed] [CrossRef] [Google Scholar]

36. Jung EH, Meyers DJ, Bosch J, Casadevall A. Novel Antifungal Compounds Discovered in Medicines for Malaria Venture's Malaria Box. mSphere. 2018;3(2). PubMed PMID: 29564402. Pubmed Central PMCID: Pmc5853493. doi: 10.1128/mSphere.00537-17 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

37. Mayer FL, Kronstad JW. Discovery of a Novel Antifungal Agent in the Pathogen Box. mSphere. 2017;2(2). PubMed PMID: 28435886. Pubmed Central PMCID: Pmc5390095. doi: 10.1128/mSphere.00120-17 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

38. Enaud R, Vandenborght LE, Coron N, Bazin T, Prevel R, Schaeverbeke T, Berger P, Fayon M, Lamireau T, Delhaes L. The Mycobiome: A Neglected Component in the Microbiota-Gut-Brain Axis. Microorganisms. 2018;6(1). PubMed PMID: 29522426. Pubmed Central PMCID: Pmc5874636. doi: 10.3390/microorganisms6010022 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

39. Ghannoum MA, Jurevic RJ, Mukherjee PK, Cui F, Sikaroodi M, Naqvi A, Gillevet PM. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLoS Pathog. 2010;6(1):e1000713 PubMed PMID: 20072605. Pubmed Central PMCID: Pmc2795202. doi: 10.1371/journal.ppat.1000713 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

40. Cui L, Morris A, Ghedin E. The human mycobiome in health and disease. Genome Med. 2013;5(7):63 PubMed PMID: 23899327. Pubmed Central PMCID: Pmc3978422. doi: 10.1186/gm467 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

41. Oever JT, Netea MG. The bacteriome-mycobiome interaction and antifungal host defense. Eur J Immunol. 2014;44(11):3182–91. PubMed PMID: 25256886. doi: 10.1002/eji.201344405 [PubMed] [CrossRef] [Google Scholar]

42. Ghannoum M. Cooperative Evolutionary Strategy between the Bacteriome and Mycobiome. MBio. 2016;7(6). PubMed PMID: 27935844. Pubmed Central PMCID: Pmc5111414. doi: 10.1128/mBio.01951-16 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

43. Kalan L, Loesche M, Hodkinson BP, Heilmann K, Ruthel G, Gardner SE, Grice EA. Redefining the Chronic-Wound Microbiome: Fungal Communities Are Prevalent, Dynamic, and Associated with Delayed Healing. MBio. 2016;7(5). PubMed PMID: 27601572. Pubmed Central PMCID: Pmc5013295. doi: 10.1128/mBio.01058-16 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

44. Vicencio AG, Santiago MT, Tsirilakis K, Stone A, Worgall S, Foley EA, Bush D, Goldman DL. Fungal sensitization in childhood persistent asthma is associated with disease severity. Pediatr Pulmonol. 2014;49(1):8–14. PubMed PMID: 23401301. doi: 10.1002/ppul.22779 [PubMed] [CrossRef] [Google Scholar]

45. Denning DW, Pashley C, Hartl D, Wardlaw A, Godet C, Del Giacco S, Delhaes L, Sergejeva S. Fungal allergy in asthma-state of the art and research needs. Clin Transl Allergy. 2014;4:14 PubMed PMID: 24735832. Pubmed Central PMCID: Pmc4005466. doi: 10.1186/2045-7022-4-14 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

46. Singh A, Ralhan A, Schwarz C, Hartl D, Hector A. Fungal Pathogens in CF Airways: Leave or Treat? Mycopathologia. 2018;183(1):119–37. PubMed PMID: 28770417. doi: 10.1007/s11046-017-0184-y [PubMed] [CrossRef] [Google Scholar]

47. Alonso R, Pisa D, Aguado B, Carrasco L. Identification of Fungal Species in Brain Tissue from Alzheimer's Disease by Next-Generation Sequencing. J Alzheimers Dis. 2017;58(1):55–67. PubMed PMID: 28387676. doi: 10.3233/jad-170058 [PubMed] [CrossRef] [Google Scholar]

48. Pisa D, Alonso R, Rabano A, Rodal I, Carrasco L. Different Brain Regions are Infected with Fungi in Alzheimer's Disease. Sci Rep. 2015;5:15015 PubMed PMID: 26468932. Pubmed Central PMCID: Pmc4606562. doi: 10.1038/srep15015 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

49. Vargas SL, Ponce CA, Luchsinger V, Silva C, Gallo M, Lopez R, Belletti J, Velozo L, Avila R, Palomino MA, Benveniste S, Avendano LF. Detection of Pneumocystis carinii f. sp. hominis and viruses in presumably immunocompetent infants who died in the hospital or in the community. J Infect Dis. 2005;191(1):122–6. PubMed PMID: 15593013. doi: 10.1086/426451 [PubMed] [CrossRef] [Google Scholar]

50. Garcia-Solache MA, Casadevall A. Global warming will bring new fungal diseases for mammals. MBio. 2010;1(1). doi: 10.1128/mBio.00061-10 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

51. de SAGR, Souza W, Frases S. The hidden pathogenic potential of environmental fungi. Future Microbiol. 2017;12:1533–40. PubMed PMID: 29168657. doi: 10.2217/fmb-2017-0124 [PubMed] [CrossRef] [Google Scholar]

52. Cohen JM, Venesky MD, Sauer EL, Civitello DJ, McMahon TA, Roznik EA, Rohr JR. The thermal mismatch hypothesis explains host susceptibility to an emerging infectious disease. Ecol Lett. 2017;20(2):184–93. PubMed PMID: 28111904. doi: 10.1111/ele.12720 [PubMed] [CrossRef] [Google Scholar]

53. Paterson RR, Lima N. Thermophilic Fungi to Dominate Aflatoxigenic/Mycotoxigenic Fungi on Food under Global Warming. Int J Environ Res Public Health. 2017;14(2). PubMed PMID: 28218685. Pubmed Central PMCID: Pmc5334753. doi: 10.3390/ijerph14020199 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

54. Beatty GW. Immune reconstitution inflammatory syndrome. Emerg Med Clin North Am. 2010;28(2):393-407, Table. S0733-8627(10)00005-2 [pii]. doi: 10.1016/j.emc.2010.01.004 [PubMed] [CrossRef] [Google Scholar]

55. Casadevall A, Pirofski L. The damage-response framework of microbial pathogenesis. Nature Microbiol Rev. 2003;1:17–24. [PMC free article] [PubMed] [Google Scholar]

56. Pirofski LA, Casadevall A. Immune-Mediated Damage Completes the Parabola: Cryptococcus neoformans Pathogenesis Can Reflect the Outcome of a Weak or Strong Immune Response. MBio. 2017;8(6). PubMed PMID: 29233901. Pubmed Central PMCID: Pmc5727418. doi: 10.1128/mBio.02063-17 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

57. Casadevall A, Coelho C, Alanio A. Mechanisms of Cryptococcus neoformans-Mediated Host Damage. Front Immunol. 2018;9:855 PubMed PMID: 29760698. Pubmed Central PMCID: Pmc5936990. doi: 10.3389/fimmu.2018.00855 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

58. Himmelreich U, Malik R, Kuhn T, Daniel HM, Somorjai RL, Dolenko B, Sorrell TC. Rapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host response. PLoS ONE. 2009;4(4):e5328. doi: 10.1371/journal.pone.0005328 [PMC free article] [PubMed] [CrossRef] [Google Scholar]

59. Pfaller MA, Wolk DM, Lowery TJ. T2MR and T2Candida: novel technology for the rapid diagnosis of candidemia and invasive candidiasis. Future Microbiol. 2016;11(1):103–17. PubMed PMID: 26371384. doi: 10.2217/fmb.15.111 [PubMed] [CrossRef] [Google Scholar]

60. Sorrell TC, Wright LC, Malik R, Himmelreich U. Application of proton nuclear magnetic resonance spectroscopy to the study of Cryptococcus and cryptococcosis. FEMS Yeast Res. 2006;6(4):558–66. [PubMed] [Google Scholar]

61. Acharige MJT, Koshy S, Ismail N, Aloum O, Jazaerly M, Astudillo CL, Koo S. Breath-based diagnosis of fungal infections. J Breath Res. 2018;12(2):027108 PubMed PMID: 29109305. doi: 10.1088/1752-7163/aa98a1 [PubMed] [CrossRef] [Google Scholar]

62. Molloy SF, Chiller T, Greene GS, Burry J, Govender NP, Kanyama C, Mfinanga S, Lesikari S, Mapoure YN, Kouanfack C, Sini V, Temfack E, Boulware DR, Dromer F, Denning DW, Day J, Stone NRH, Bicanic T, Jarvis JN, Lortholary O, Harrison TS, Jaffar S, Loyse A. Cryptococcal meningitis: A neglected NTD? PLoS Negl Trop Dis. 2017;11(6):e0005575 PubMed PMID: 28662028. Pubmed Central PMCID: Pmc5490932. doi: 10.1371/journal.pntd.0005575 [PMC free article] [PubMed] [CrossRef] [Google Scholar]